CN107823383A - 用于治疗股骨头坏死的口服中药 - Google Patents
用于治疗股骨头坏死的口服中药 Download PDFInfo
- Publication number
- CN107823383A CN107823383A CN201711259353.3A CN201711259353A CN107823383A CN 107823383 A CN107823383 A CN 107823383A CN 201711259353 A CN201711259353 A CN 201711259353A CN 107823383 A CN107823383 A CN 107823383A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- corydalis tuber
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 230000017074 necrotic cell death Effects 0.000 title claims abstract description 46
- 210000002391 femur head Anatomy 0.000 title claims abstract description 37
- 241000218176 Corydalis Species 0.000 claims abstract description 35
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 22
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 22
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 22
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 22
- 241000427159 Achyranthes Species 0.000 claims abstract description 18
- 241000255789 Bombyx mori Species 0.000 claims abstract description 18
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 18
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 18
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 18
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 18
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 18
- 241000237502 Ostreidae Species 0.000 claims abstract description 18
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 235000020636 oyster Nutrition 0.000 claims abstract description 18
- 235000005412 red sage Nutrition 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 17
- 241000208688 Eucommia Species 0.000 claims abstract description 17
- 241000270295 Serpentes Species 0.000 claims abstract description 17
- 241001278833 Rosa laevigata Species 0.000 claims abstract description 16
- 235000000661 Rosa laevigata Nutrition 0.000 claims abstract description 16
- 244000189799 Asimina triloba Species 0.000 claims description 18
- 235000006264 Asimina triloba Nutrition 0.000 claims description 18
- 235000009467 Carica papaya Nutrition 0.000 claims description 18
- 241001647745 Banksia Species 0.000 claims description 17
- 241000112528 Ligusticum striatum Species 0.000 claims description 17
- 241000195947 Lycopodium Species 0.000 claims description 17
- 241000220317 Rosa Species 0.000 claims description 17
- 241000304432 Sedum sarmentosum Species 0.000 claims description 16
- 239000000203 mixture Substances 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 53
- 239000008280 blood Substances 0.000 description 52
- 208000002193 Pain Diseases 0.000 description 41
- 206010028851 Necrosis Diseases 0.000 description 37
- 230000036407 pain Effects 0.000 description 37
- 210000003734 kidney Anatomy 0.000 description 24
- 210000000988 bone and bone Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 230000017531 blood circulation Effects 0.000 description 16
- 210000003205 muscle Anatomy 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000001624 hip Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 230000000202 analgesic effect Effects 0.000 description 12
- 235000005686 eating Nutrition 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 10
- 210000003127 knee Anatomy 0.000 description 8
- 210000002435 tendon Anatomy 0.000 description 8
- 208000014674 injury Diseases 0.000 description 7
- 239000006187 pill Substances 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000002040 relaxant effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 208000015813 Familial avascular necrosis of femoral head Diseases 0.000 description 6
- 208000007875 Femur Head Necrosis Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000002146 bilateral effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 231100000862 numbness Toxicity 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 5
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 5
- 240000006108 Allium ampeloprasum Species 0.000 description 5
- 206010051728 Bone erosion Diseases 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000000913 Kidney Calculi Diseases 0.000 description 5
- 206010029148 Nephrolithiasis Diseases 0.000 description 5
- 244000300264 Spinacia oleracea Species 0.000 description 5
- 235000009337 Spinacia oleracea Nutrition 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 description 5
- 239000001506 calcium phosphate Substances 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 201000001883 cholelithiasis Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000001130 gallstones Diseases 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000008765 Sciatica Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 206010044684 Trismus Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 210000004394 hip joint Anatomy 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001114 myogenic effect Effects 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000001694 thigh bone Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010031264 Osteonecrosis Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 244000000053 intestinal parasite Species 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000003137 locomotive effect Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000020764 Sensation disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 201000008587 ulcerative stomatitis Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000009184 walking Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
用于治疗股骨头坏死的口服中药。股骨头坏死病人手术有风险,手术费用高以及不能根除。本发明组成包括重量份数为4‑15的丹参,重量份数为2‑6的乳香,重量份数为2‑6的没药,重量份数为9‑12的鹿角霜,重量份数为1‑5的龙骨,重量份数4‑15的牡蛎,重量份数为3‑10的夏天无,重量份数为1‑5的红花,重量份数为2‑6的僵蚕,重量份数为2‑8的蛇蜕,重量份数为4‑15的山药,重量份数为3‑10的杜仲,重量份数为2‑6的牛膝,重量份数为2‑8的延胡索,重量份数为3‑10的汉桃叶,重量份数为2‑8的金樱子。本发明用于治疗股骨头坏死的口服中药。
Description
技术领域:
本发明涉及一种用于治疗股骨头坏死的口服中药。
背景技术:
股骨头坏死亦称股骨头无菌性坏死和股骨头缺血性坏死,它是骨伤科临床常 见而又难治的慢性疾病之一。股骨头坏死是由于髋部外伤,长期应用激素类药物,酒精中毒等原因,引起股骨头血液供应障碍,股骨头骨组织不能得到正常的营养,使股骨头组织中的骨细胞,骨髓造血细胞,脂肪细胞发生坏死。因此股骨头坏死的根本治疗方法是改善股骨头内的血液供应,恢复股骨头内的血液循环,保证股骨组织的营养充足,从而促进死骨吸收、新骨形成、防止和纠正股骨头塌陷。由于坏死的 骨组织脆弱,加之髋关节需要负重,日久就会发生股骨头塌陷,影响全部髋关节。本病有“轻则致残,重则致瘫”的说法。
概述股骨头坏死在中医上被称为“骨蚀”。中医认为机体体质虚弱,抗病能力低下,肝肾精血不足,致使骨质疏松,是股骨头缺血性坏死的潜在原因。病变涉及肝、脾、肾。肾为先天之本,主骨生髓,肾健则髓生,髓满则骨坚。反之,则髓枯萎,失去应有的再生能力。肝主筋藏血与肾同源,二者荣衰与共,若肝脏受累、藏血失司,不能正常调节血量,血液营运不周,营养难济,是造成股骨头坏死的重要因素。脾主运血,脾失健运、无化气源,则筋骨肌肉皆无气以生。病变发生后,骨与软骨挫裂伤,气血不通畅,经脉瘀阻,血行障碍,肢体失去营养,再生和修复能力减退,因而产生本病。
中医理论认为,股骨头缺血性坏死早期、中晚期以筋脉瘀滞为主,晚期常伴有肝肾不足,激素型或酗酒型常伴有滞湿蕴藉。股骨头却训醒坏死一旦发生,多数患者会经历“缺血坏死——塌陷——骨性关节炎”的“痛苦三部曲”,病程从数月到数年不等。
自1888年世界医学界首次认识股骨头坏死这一疾病至今,股骨头坏死已由少见病转变为多发病、常见病。尤其是激素的问世及其广泛应用以来,股骨头坏死的发病率逐渐上升。加之交通工具变革后变通事故的增多,人们生活方式的改变均使得该病患者数量剧增。据不完全统计,目前全世界股骨头坏死3000万人,我国约有400万人。最新的调查表明,股骨头坏死的发生无明显性别差异,任何年龄均可患病,而有过激素应用史、髋部外伤史、酗酒史、相关疾病史者发病的机率明显增多。
股骨头坏死可发生于任何年龄但以31-60岁最多,无性别差异,开始多表现为髋关节或其周围关节的隐痛、钝痛,活动后加重,进一步发展可导致髋关节的功能障碍,股骨头坏死严重影响患者的生活质量和劳动能力,若治疗不及时,还可导致终身残疾。
股骨头坏死在西医上一直是“无药可医”,目前西医对早中期股骨头坏死患者几乎束手无策,作为短期缓解症状,国内外专家均主张早期坏死采取姑息手术,如:核心减压、带血管骨移植术、血管植入术、骨支架术等。晚期不可避免的行人工关节置换术等。但总体看来,手术疗法因其痛苦大、费用高、恢复期长、局限性广、远期效果不能尽善尽美等而不被众多患者所接受。真正股骨头坏死并不多见,大多数是将远伤(久远的软组织损伤)误诊为股骨坏死。其症状基本相同,但治疗方法则完全不一样,是比较容易治好的疾病。
据美国费吉尼亚大学专家统计,全世界股骨头缺血性坏死病人,大约50%左右在40岁以前只换了人工股骨头,术后5年内失败率大约10%—50%。而且目前最好的人工股骨头也只能使用10—15年。一生中多次更换人工股骨头不仅费用高,而且对患者伤害大,心理上也难以接受,而且部分患者手术置换人工股骨头后远期疗效仍然不尽人意,数月和数年后还会出现疼痛。
发明内容:
本发明的目的是针对股骨头坏死病人手术有风险,手术费用高以及不能根除的现象,提供一种可以根治股骨头坏死,无不良反应以及毒副作用的用于治疗股骨头坏死的口服中药。
上述的目的通过以下的技术方案实现:
一种用于治疗股骨头坏死的口服中药,所述的中药包括重量份数为4-15的丹参,重量份数为2-6的乳香,重量份数为2-6的没药,重量份数为9-12的鹿角霜,重量份数为1-5的龙骨,重量份数4-15的牡蛎,重量份数为3-10的夏天无,重量份数为1-5的红花,重量份数为2-6的僵蚕,重量份数为2-8的蛇蜕,重量份数为4-15的山药,重量份数为3-10的杜仲,重量份数为2-6的牛膝,重量份数为2-8的延胡索,重量份数为3-10的汉桃叶,重量份数为2-8的金樱子,重量份数为5-13的木瓜,重量份数为2-6的木香,重量份数为2-6的香附,重量份数为2-6的川芎,重量份数为3-10的垂盆草,重量份数为3-10的伸筋草,重量份数为3-10的防风。
所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为6-12,所述的乳香的重量份数为3-5,所述的没药的重量份数为3-5,所述的鹿角霜的重量份数为10-11,所述的龙骨的重量份数为2-4,所述的牡蛎的重量份数6-12,所述的夏天无的重量份数为4-8,所述的红花的重量份数为2-4,所述的僵蚕的重量份数为3-5,所述的蛇蜕的重量份数为3-7,所述的山药的重量份数为6-12,所述的杜仲的重量份数为4-8,所述的牛膝的重量份数为3-5,所述的延胡索的重量份数为3-7,所述的汉桃叶的重量份数为4-8,所述的金樱子的重量份数为3-7,所述的木瓜的重量份数为7-10,所述的木香的重量份数为3-5 ,所述的香附的重量份数为3-5,所述的川芎的重量份数为3-5,所述的垂盆草的重量份数为4-8,所述的伸筋草的重量份数为4-8,所述的防风的量份数为4-8。
所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为4,所述的乳香的重量份数为2,所述的没药的重量份数为2,所述的鹿角霜的重量份数为9,所述的龙骨的重量份数为1,所述的牡蛎的重量份数4,所述的夏天无的重量份数为3,所述的红花的重量份数为1,所述的僵蚕的重量份数为2,所述的蛇蜕的重量份数为2,所述的山药的重量份数为4,所述的杜仲的重量份数为3,所述的牛膝的重量份数为2,所述的延胡索的重量份数为2,所述的汉桃叶的重量份数为3,所述的金樱子的重量份数为2,所述的木瓜的重量份数为5,所述的木香的重量份数为2,所述的香附的重量份数为2,所述的川芎的重量份数为2,所述的垂盆草的重量份数为3,所述的伸筋草的重量份数为3,所述的防风的量份数为3。
所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为15,所述的乳香的重量份数为6,所述的没药的重量份数为6,所述的鹿角霜的重量份数为12,所述的龙骨的重量份数为5,所述的牡蛎的重量份数15,所述的夏天无的重量份数为10,所述的红花的重量份数为5,所述的僵蚕的重量份数为6,所述的蛇蜕的重量份数为8,所述的山药的重量份数为15,所述的杜仲的重量份数为10,所述的牛膝的重量份数为6,所述的延胡索的重量份数为8,所述的汉桃叶的重量份数为10,所述的金樱子的重量份数为8,所述的木瓜的重量份数为13,所述的木香的重量份数为6,所述的香附的重量份数为6,所述的川芎的重量份数为6,所述的垂盆草的重量份数为10,所述的伸筋草的重量份数为10,所述的防风的量份数为10。
所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为8,所述的乳香的重量份数为4,所述的没药的重量份数为4,所述的鹿角霜的重量份数为10,所述的龙骨的重量份数为3,所述的牡蛎的重量份数8,所述的夏天无的重量份数为6,所述的红花的重量份数为3,所述的僵蚕的重量份数为4,所述的蛇蜕的重量份数为5,所述的山药的重量份数为8,所述的杜仲的重量份数为6,所述的牛膝的重量份数为4,所述的延胡索的重量份数为5,所述的汉桃叶的重量份数为6,所述的金樱子的重量份数为5,所述的木瓜的重量份数为9,所述的木香的重量份数为4 ,所述的香附的重量份数为4,所述的川芎的重量份数为4,所述的垂盆草的重量份数为6,所述的伸筋草的重量份数为5,所述的防风的量份数为7。
有益效果:
1.本发明可以改善股骨头内的血液供应,恢复股骨头内的血液循环,保证股骨组织的营养充足,从而促进死骨吸收、新骨形成、防止和纠正股骨头塌陷,根治股骨头坏死。
本发明组方功效和药物原理如下:
丹参:活血化瘀,除风邪湿,热骨节疼痛,破宿血补新血,久服利人气;
丹参和本发明的其他药品配伍后相互协同作用具有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,***,血瘀,腹痛,经痛,经闭,庙痛。对治疗冠心病有良好效果。此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎,外用又可洗漆疮。
乳香:活血行气,用于气滞血瘀,通达脏腑经络;
乳香和本发明的其他药品配伍后相互协同作用具有调气活血,定痛,追毒。治气血凝滞、心腹疼痛,痈疮肿毒,跌打损伤,痛经,产后瘀血刺痛,疗风水毒肿,去恶气,疗风瘾疹痒毒,疗耳聋,中风口噤,妇人血气,能发酒,理风冷,止大肠泄澼,疗诸疮令内消,止霍乱,心腹痛。煎膏止痛长肉,治不眠,定诸经之痛,消痈疽诸毒,托里护心,活血定痛,伸筋,治妇人难产,折伤,治癫狂,止泄痢,赤白痢腹痛不止者,加入乳香无不效。
没药:消肿止痛生肌,筋骨诸痛损伤,瘀血散血去淤;
没药和本发明的其他药品配伍后相互协同作用具有活血散瘀、行气舒筋,活血散瘀、消肿止痛,活血散瘀、止痛,消肿生肌、燥湿解毒。
鹿角霜:补肾壮阳,腰膝酸痛,肾阳不足,通血脉;蛇蜕:驱风散寒,主含人体骨骼所需骨胶原;
鹿角霜和本发明的其他药品配伍后相互协同作用具有补肾助阳,收敛止血的功效,主治肾阳不足,腰膝冷痛,阳痿遗精,尿频遗尿,脾胃虚寒,食少便溏,崩漏带下,创伤出血,疮疡久不愈合;
牡蛎:软坚散结,补肾壮阳之正气,止汗去烦,久服强骨骼;
牡蛎和本发明的其他药品配伍后相互协同作用具有安神之功效,用治心神不安,惊悸怔忡,失眠多梦等症,肝阳上亢,头晕目眩,该品咸寒质重,入肝经,有平肝潜阳,益阴之功,用治水不涵木,阴虚阳亢,头目眩晕,烦躁不安;
龙骨:益肾固精生肌,收气血除湿气;
龙骨和本发明的其他药品配伍后相互协同作用具有重镇安神镇惊安神,敛汗固精,止血涩肠,生肌敛疮。治惊痫癫狂,怔忡健忘,失眠多梦,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,溃疡久不收口。
夏天无:止痛行气活血,关节痛腰肌劳损,对于各种坐骨神经痛、风湿性关节痛有缓解关节僵硬,促进患肢功能恢复功效;
夏天无和本发明的其他药品配伍后相互协同作用具有降压、镇静,舒筋、活络、止痛租用,用于治疗坐骨神经痛、风湿性关节炎、骨折及扭伤、小儿麻痹症等,有止痛,消肿,缓解关节僵硬,促进患肢功能恢复,加速骨折愈合等效果;
红花:散瘀血不消,经脉不通,活血化瘀;
红花和本发明的其他药品配伍后相互协同作用具有活血通经、散瘀止痛功效,用于经闭、痛经、恶露不行、症瘕痞块、跌打损伤,古人常有於血在体内时,常加红花一小把,适用各种静脉曲张,末梢神经炎,血液循环不好,腿脚麻木或青紫等淤血症。
白僵蚕:活络通经,驱风开辟,治一切风,化痰散湿气,能通行血脉余痛;
白僵蚕和本发明的其他药品配伍后相互协同作用具有祛风解痉,化痰散结,治中风失音,惊痫,头风,喉风,喉痹,瘰疬结核,风疮瘾疹,丹毒,乳腺炎,去三虫,灭黑黚,男子阴疡病,用于产后余痛,灭诸疮瘢痕,治口噤,发汗,主妇人崩中下血不止,治中风,急喉痹,捣筛细末,去皮肤间诸风,散风痰结核,瘰疬,头风,风虫齿痛,皮肤风疮,丹毒作痒,痰疟症结,妇人乳汁不通,崩中下血,小儿疳蚀鳞体,一切金疮,疔肿风痔,治小儿疳蚀,牙龈溃烂,重舌,木舌。活络通经,驱风开痹,治头痛胸痹,口噤牙疼,瘾疹风瘙;烧研酒服,能溃痈破顶,又治血淋崩中。
山药:破瘀血,补五劳七伤,去冷风止痛,助五脏,强筋骨,温养肌肉;
山药和本发明的其他药品配伍后相互协同作用具有健脾胃、补肺肾、补中益气、健脾补虚,固肾益精、益心安神等作用,有消渴生之功效,可以防治人体脂质代谢异常,以及动脉硬化,对维护胰岛素正常功能也有一定作用,有增强人体免疫力,益心安神,宁咳定喘,延缓衰老等保健作用
山药中的铜离子与***对人体发育有极大帮助,对血管***疾病有明显疗效,铁棍山药中的钙,对伤筋损骨、骨质疏松,牙齿脱落有极高的疗效,对冻疮、糖尿病、肝炎、小儿泻泄、遗尿症、婴儿消化不良、溃疡性口腔炎、肺结核、妇女月经带下等患者也有很好的疗效,久用可耳聪目明,延年益寿,山药中富含大量蛋白质、B族维生素、维生素C、维生素E、葡萄糖、粗蛋白氨基酸、胆汁碱、尿囊素等;其中重要的营养成分薯蓣皂是合成女性荷尔蒙的先驱物质,滋阴补阳、增强新陈代谢的功效;而新鲜块茎中含有的多糖蛋白成分的粘液质、消化酵素等,可预防心血管脂肪沉积,有助于胃肠的消化和吸收。
杜仲:补肝肾,强筋骨,治腰膝酸软,补中益气,祛关节湿气;
杜仲和本发明的其他药品配伍后相互协同作用具有治疗腰膝痛,补中,益精气,坚筋骨,除阴下痒湿,小便余沥。久服,轻身耐老等功效;
牛膝:补肾填精,逐恶血流,助十二经脉,止筋骨痛,腰膝骨痛;
牛膝和本发明的其他药品配伍后相互协同作用具有治疗寒湿痿痹,四肢拘挛、膝痛不可屈伸者,肝脾肾虚,则寒湿之邪客之而成痹,及病四肢拘挛,膝痛不可屈伸。此药性走而下行,其能逐寒湿而除痹也必矣。盖补肝则筋舒,下行则理膝,行血则痛止。逐血气,犹云能通气滞血凝也。详药性,气当作痹。伤热火烂,血焦枯之病也,血行而活,痛自止矣。入肝行血,故堕胎。伤中少气,男子阴消,老人失溺者,皆肾不足之候也。脑为髓之海,脑不满则空而痛。腰乃肾之腑,脊通髓于脑,肾虚髓少,则腰脊痛;血虚而热,则发白。虚赢劳顿,则伤绝。肝藏血,肾藏精,峻补肝肾,则血足而精满,诸证自瘳矣。血行则月水自通,血结自散;
延胡索:有良好的止痛作用,暖腰膝,行血去淤,治一身上下诸痛;
延胡索和本发明的其他药品配伍后相互协同作用具有治疗妇人***,腹中结块,崩中淋露,产后诸血病,血运,暴血冲上,因损下血,除风治气,暖腰膝,止暴腰痛,破症癖,扑损瘀血,,治心气小腹痛,散气,治肾气,通经络,活血利气,止痛,通小便;
汉桃叶:祛风除湿,活血止痛,壮筋骨疗腰腿疼;
汉桃叶和本发明的其他药品配伍后相互协同作用具有祛风止痛、舒筋活络功能,用于三叉神经痛、神经性头痛、坐骨神经痛、风湿关节痛及胃、肠、胆道疼痛等症;
金樱子:固精润肠,壮筋骨补五脏,养气血生***,益精髓;
木瓜:去湿舒筋,主湿痺邪气,强筋骨;
木瓜和本发明的其他药品配伍后相互协同作用具有补偿胰和肠道的分泌,补充胃液的不足,有助于分解蛋白质和淀粉。木瓜含有胡萝卜素和丰富的维生素C,它们有很强的抗氧化能力,帮助机体修复组织,消除有毒物质,增强人体免疫力,帮助机体抵抗包括甲流在内的病毒侵袭,木瓜果实中的有效成分能提高吞噬细胞的功效。
木香:顺逆气,通理气,温肾气,温寒气,疗气滞诸痛;
木香和本发明的其他药品配伍后相互协同作用具有通气,和合五脏,为调诸气要药,以此治痞闷嗳气,水肿腹胀,痢疾脚气,皆调滞散气之功,但辛香属阳,阳则升浮,如中焦、下焦结滞,须佐槟榔堕之下行,因性香燥,同黄连、黄芩治痢疾,同黄柏、防己治脚气,皆藉寒药而制其燥,则用斯神矣,若怒气拂逆攻冲,遍身作痛,以此使肺气调,则肺气自伏,若肝气郁,致胁肋小腹间痛,同青皮疏之,令肝气行,则血顺痛止;
香附:兼行十二经脉,理气解郁,止痛调经,气郁不舒,调血中之气;
香附和本发明的其他药品配伍后相互协同作用具有理气解郁,调经止痛,用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,***,经闭痛经,寒疝腹痛,***胀痛。
川芎:驱风活血止痛,腰腿酸弱,疗一切风、一切气、一切血,壮筋骨补五劳,破宿血养新血,排脓消瘀血;
川芎和本发明的其他药品配伍后相互协同作用具有活血行气,祛风止痛,用于安抚神经,正头风头痛,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
垂盆草:消炎消肿止痛,促进软组织化脓性感染吸收;
伸筋草:驱风散寒,舒筋活血,除湿消肿,祛年久之坚积,消水肿止痛,腰腿酸痛,风湿性关节肿痛;
伸筋草和本发明的其他药品配伍后相互协同作用具有治疗脚膝疼冷,皮肤不仁,气力衰弱,舒筋活血,补气通络,治腰痛,关节痛,闭经,治筋骨,通关节,治腰痛及胯,腿等痛症。
防风:散风寒湿癖,行经络,通关节止痛,舒筋骨活肢节,疗骨节痛痺。
具体实施方式:
实施例1:
一种用于治疗股骨头坏死的口服中药,其特征是:所述的中药包括重量份数为4-15的丹参,重量份数为2-6的乳香,重量份数为2-6的没药,重量份数为9-12的鹿角霜,重量份数为1-5的龙骨,重量份数4-15的牡蛎,重量份数为3-10的夏天无,重量份数为1-5的红花,重量份数为2-6的僵蚕,重量份数为2-8的蛇蜕,重量份数为4-15的山药,重量份数为3-10的杜仲,重量份数为2-6的牛膝,重量份数为2-8的延胡索,重量份数为3-10的汉桃叶,重量份数为2-8的金樱子,重量份数为5-13的木瓜,重量份数为2-6的木香,重量份数为2-6的香附,重量份数为2-6的川芎,重量份数为3-10的垂盆草,重量份数为3-10的伸筋草,重量份数为3-10的防风。
上述重量配比的原料加工成120目以上的药粉,并混合均匀,制成散剂,水丸,密丸剂,也可以制成颗粒剂;
服用方法:一日三次,每次8克,饭后服用,三个月为一个疗程;
忌食:此药在治疗期间主要是以补钙和补骨胶原为主到,在服用药物期间,忌食,菠菜,韭菜,鱼这些食物当中含有大量的草酸钙,磷酸钙,用意产生胆肾结石的形成,切记。
实施例2:
根据实施例1所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为6-12,所述的乳香的重量份数为3-5,所述的没药的重量份数为3-5,所述的鹿角霜的重量份数为10-11,所述的龙骨的重量份数为2-4,所述的牡蛎的重量份数6-12,所述的夏天无的重量份数为4-8,所述的红花的重量份数为2-4,所述的僵蚕的重量份数为3-5,所述的蛇蜕的重量份数为3-7,所述的山药的重量份数为6-12,所述的杜仲的重量份数为4-8,所述的牛膝的重量份数为3-5,所述的延胡索的重量份数为3-7,所述的汉桃叶的重量份数为4-8,所述的重金樱子的重量份数为3-7,所述的木瓜的重量份数为7-10,所述的木香的重量份数为3-5 ,所述的香附的重量份数为3-5,所述的川芎的重量份数为3-5,所述的垂盆草的重量份数为4-8,所述的伸筋草的重量份数为4-8,所述的防风的量份数为4-8。
上述重量配比的原料加工成120目以上的药粉,并混合均匀,制成散剂,水丸,密丸剂,也可以制成颗粒剂;
服用方法:一日三次,每次8克,饭后服用,三个月为一个疗程;
忌食:此药在治疗期间主要是以补钙和补骨胶原为主到,在服用药物期间,忌食,菠菜,韭菜,鱼这些食物当中含有大量的草酸钙,磷酸钙,用意产生胆肾结石的形成,切记。
实施例3:
根据实施例1所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为4,所述的乳香的重量份数为2,所述的没药的重量份数为2,所述的鹿角霜的重量份数为9,所述的龙骨的重量份数为1,所述的牡蛎的重量份数4,所述的夏天无的重量份数为3,所述的红花的重量份数为1,所述的僵蚕的重量份数为2,所述的蛇蜕的重量份数为2,所述的山药的重量份数为4,所述的杜仲的重量份数为3,所述的牛膝的重量份数为2,所述的延胡索的重量份数为2,所述的汉桃叶的重量份数为3,所述的金樱子的重量份数为2,所述的木瓜的重量份数为5,所述的木香的重量份数为2,所述的香附的重量份数为2,所述的川芎的重量份数为2,所述的垂盆草的重量份数为3,所述的伸筋草的重量份数为3,所述的防风的量份数为3。
上述重量配比的原料加工成120目以上的药粉,并混合均匀,制成散剂,水丸,密丸剂,也可以制成颗粒剂;
服用方法:一日三次,每次8克,饭后服用,三个月为一个疗程;
忌食:此药在治疗期间主要是以补钙和补骨胶原为主到,在服用药物期间,忌食,菠菜,韭菜,鱼这些食物当中含有大量的草酸钙,磷酸钙,用意产生胆肾结石的形成,切记。
实施例4:
根据实施例1所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为15,所述的乳香的重量份数为6,所述的没药的重量份数为6,所述的鹿角霜的重量份数为12,所述的龙骨的重量份数为5,所述的牡蛎的重量份数15,所述的夏天无的重量份数为10,所述的红花的重量份数为5,所述的僵蚕的重量份数为6,所述的蛇蜕的重量份数为8,所述的山药的重量份数为15,所述的杜仲的重量份数为10,所述的牛膝的重量份数为6,所述的延胡索的重量份数为8,所述的汉桃叶的重量份数为10,所述的重金樱子的重量份数为8,所述的木瓜的重量份数为13,所述的木香的重量份数为6,所述的香附的重量份数为6,所述的川芎的重量份数为6,所述的垂盆草的重量份数为10,所述的伸筋草的重量份数为10,所述的防风的量份数为10;
上述重量配比的原料加工成120目以上的药粉,并混合均匀,制成散剂,水丸,密丸剂,也可以制成颗粒剂;
服用方法:一日三次,每次8克,饭后服用,三个月为一个疗程;
忌食:此药在治疗期间主要是以补钙和补骨胶原为主到,在服用药物期间,忌食,菠菜,韭菜,鱼这些食物当中含有大量的草酸钙,磷酸钙,用意产生胆肾结石的形成,切记。
实施例5:
根据实施例1所述的用于治疗股骨头坏死的口服中药,所述的丹参的重量份数为8,所述的乳香的重量份数为4,所述的没药的重量份数为4,所述的鹿角霜的重量份数为10,所述的龙骨的重量份数为3,所述的牡蛎的重量份数8,所述的夏天无的重量份数为6,所述的红花的重量份数为3,所述的僵蚕的重量份数为4,所述的蛇蜕的重量份数为5,所述的山药的重量份数为8,所述的杜仲的重量份数为6,所述的牛膝的重量份数为4,所述的延胡索的重量份数为5,所述的汉桃叶的重量份数为6,所述的重金樱子的重量份数为5,所述的木瓜的重量份数为9,所述的木香的重量份数为4 ,所述的香附的重量份数为4,所述的川芎的重量份数为4,所述的垂盆草的重量份数为6,所述的伸筋草的重量份数为5,所述的防风的量份数为7;
上述重量配比的原料加工成120目以上的药粉,并混合均匀,制成散剂,水丸,密丸剂,也可以制成颗粒剂;
服用方法:一日三次,每次8克,饭后服用,三个月为一个疗程;
忌食:此药在治疗期间主要是以补钙和补骨胶原为主到,在服用药物期间,忌食,菠菜,韭菜,鱼这些食物当中含有大量的草酸钙,磷酸钙,用意产生胆肾结石的形成,切记。
本发明临床治疗效果如下:
吴兴学:男、64岁、吉林省白城市保平乡一队,双侧股骨头坏死2期,病史2年,发病原因是感冒打吊瓶药里添加激素治疗,感冒期间喝酒一周后出现双侧股骨头酸痛,误以为是风湿,治疗二个月后出现走路跛行,后去医院做X光排片检查定位2期双侧激素性股骨头坏死,来我诊所就医治疗,服用本诊所家传治疗股骨头坏死的药物骨蚀散,一周后酸痛症状逐渐减轻,连续服用一个疗程(三个月)感觉一切正常,又服用一个疗程后检查结果双侧股骨头正常;
张金宗,男、57岁,吉林省白城市保平乡二队,左侧股骨头坏死,X光检查1期,病史8个月,发病原因是外伤性导致左侧股骨头坏死,来本诊所治疗服用家传骨蚀散一周后疼痛症状见轻,一个月后感觉正常,连续服用一个疗程(三个月)排X光片检查左侧股骨头恢复正常;
李桂香,女、59岁,黑龙江省泰来县,病史3年,发病原因是激素导致双侧股骨头坏死2期,3年内不断治疗服用很多治疗股骨头坏死的药物,未见明显好转但是也未见发展,后经亲属介绍来本诊所治疗,服用本诊所骨蚀散一个疗程(三个月)后可做一些轻微家务行走自如,又服用一个疗程X光片检查双侧股骨头恢复正常;
吴丽华,女、46岁,吉林省白城市金属公司,右侧股骨头坏死1期激素性,病史一年,起初治疗过敏性哮喘药物含有激素导致股骨头坏死,后经过朋友介绍来我诊所就医,服用本诊所家传骨蚀散一个月后病情逐渐好转,连续服用二个疗程拍片检查结果右侧股骨头一切正常;
朱林,男、28岁,吉林省白城市邮局,激素性股骨头坏死2期,病史二年多,起初治疗荨麻疹服用含有激素药物,患者在治疗期间饮酒导致出现双侧激素性股骨头坏死,X光拍片检查,双侧骨小梁囊性区积液、股骨头塌陷改变,走路跛行,医院建议手术更换股骨头,后经亲属介绍来本诊所治疗,服用我家传骨蚀散一个疗程(三个月)后症状全部改善,连续服用三个疗程后拍片检查完全康复双侧股骨头正常;
杨光,男、32岁,吉林省镇赉县雅光口腔门诊,左侧股骨头坏死,病史半年左右,感觉左侧股骨头区经常出现酸胀痛,X光拍片检查左侧缺血性无菌性股骨头坏死,来本诊所治疗服用我家传骨蚀散,一周后感觉酸痛症状见轻,连服用一个疗程(三个月)后拍片检查一切正常;
朱红德,男、52岁,吉林省白城市铁路机务段,病史一年多,发病原因是工作期间对机车检修过程中发生左侧碰撞,碰撞后本以为没事,自己在药店买一些治疗跌打损伤的药物治疗,吃一段药物后未见好转,走路出现跛行现象后经拍片检查,诊断为1期外伤性左侧股骨头坏死,期间休假开始治疗,治疗期间用过很多治疗股骨头的药物未见好转,后经介绍来我诊所治疗,连续服用一个疗程的骨蚀散后排片检查一切恢复正常,重返工作岗位;
王军,男、41岁,吉林省镇赉县永发机电商店,病史一年之久,发病原因经常喝酒导致出现双侧股骨头区经常出现酸痛,拍片检查1期双侧股骨头坏死,来本诊所治疗,服用我家传骨蚀散二周后酸痛症状基本消失,连续服用二个疗程检查一切正常,后又巩固一个疗程;
徐财,男、65岁,吉林省镇赉县草原管理站,来本诊所就医自己叙述症状是腰间盘突出压迫右侧坐骨神经痛,临床检查为右侧股骨头,拍片检查结果右侧股骨头坏死,开始服用本诊所家传药物骨蚀散服,用期间有明显好转反应,连续服用治疗二个疗程再拍片检查,结果正常;
徐福,男、67岁,吉林省镇赉黑鱼泡子乡,此患者是上述病例9徐财的哥哥,发病原因是左侧股骨头区酸胀痛,和其弟叙述疼痛病情,其弟听后感觉发病症状类似自己当初一样,和其哥哥说来县里医院拍片检查一下吧,后来医院拍片检查结果左侧无菌性股骨头坏死1期,检查后来本诊所服用骨蚀散,二个疗程后一切正常,现在劳动一切正常,未出现疼痛症状。
Claims (5)
1.一种用于治疗股骨头坏死的口服中药,其特征是:所述的中药包括重量份数为4-15的丹参,重量份数为2-6的乳香,重量份数为2-6的没药,重量份数为9-12的鹿角霜,重量份数为1-5的龙骨,重量份数4-15的牡蛎,重量份数为3-10的夏天无,重量份数为1-5的红花,重量份数为2-6的僵蚕,重量份数为2-8的蛇蜕,重量份数为4-15的山药,重量份数为3-10的杜仲,重量份数为2-6的牛膝,重量份数为2-8的延胡索,重量份数为3-10的汉桃叶,重量份数为2-8的金樱子,重量份数为5-13的木瓜,重量份数为2-6的木香,重量份数为2-6的香附,重量份数为2-6的川芎,重量份数为3-10的垂盆草,重量份数为3-10的伸筋草,重量份数为3-10的防风。
2.根据权利要求1所述的用于治疗股骨头坏死的口服中药,其特征是:所述的丹参的重量份数为6-12,所述的乳香的重量份数为3-5,所述的没药的重量份数为3-5,所述的鹿角霜的重量份数为10-11,所述的龙骨的重量份数为2-4,所述的牡蛎的重量份数6-12,所述的夏天无的重量份数为4-8,所述的红花的重量份数为2-4,所述的僵蚕的重量份数为3-5,所述的蛇蜕的重量份数为3-7,所述的山药的重量份数为6-12,所述的杜仲的重量份数为4-8,所述的牛膝的重量份数为3-5,所述的延胡索的重量份数为3-7,所述的汉桃叶的重量份数为4-8,所述的重金樱子的重量份数为3-7,所述的木瓜的重量份数为7-10,所述的木香的重量份数为3-5 ,所述的香附的重量份数为3-5,所述的川芎的重量份数为3-5,所述的垂盆草的重量份数为4-8,所述的伸筋草的重量份数为4-8,所述的防风的量份数为4-8。
3.根据权利要求1所述的用于治疗股骨头坏死的口服中药,其特征是:所述的丹参的重量份数为4,所述的乳香的重量份数为2,所述的没药的重量份数为2,所述的鹿角霜的重量份数为9,所述的龙骨的重量份数为1,所述的牡蛎的重量份数4,所述的夏天无的重量份数为3,所述的红花的重量份数为1,所述的僵蚕的重量份数为2,所述的蛇蜕的重量份数为2,所述的山药的重量份数为4,所述的杜仲的重量份数为3,所述的牛膝的重量份数为2,所述的延胡索的重量份数为2,所述的汉桃叶的重量份数为3,所述的金樱子的重量份数为2,所述的木瓜的重量份数为5,所述的木香的重量份数为2,所述的香附的重量份数为2,所述的川芎的重量份数为2,所述的垂盆草的重量份数为3,所述的伸筋草的重量份数为3,所述的防风的量份数为3。
4.根据权利要求1所述的用于治疗股骨头坏死的口服中药,其特征是:所述的丹参的重量份数为15,所述的乳香的重量份数为6,所述的没药的重量份数为6,所述的鹿角霜的重量份数为12,所述的龙骨的重量份数为5,所述的牡蛎的重量份数15,所述的夏天无的重量份数为10,所述的红花的重量份数为5,所述的僵蚕的重量份数为6,所述的蛇蜕的重量份数为8,所述的山药的重量份数为15,所述的杜仲的重量份数为10,所述的牛膝的重量份数为6,所述的延胡索的重量份数为8,所述的汉桃叶的重量份数为10,所述的重金樱子的重量份数为8,所述的木瓜的重量份数为13,所述的木香的重量份数为6,所述的香附的重量份数为6,所述的川芎的重量份数为6,所述的垂盆草的重量份数为10,所述的伸筋草的重量份数为10,所述的防风的量份数为10。
5.根据权利要求1所述的用于治疗股骨头坏死的口服中药,其特征是:所述的丹参的重量份数为8,所述的乳香的重量份数为4,所述的没药的重量份数为4,所述的鹿角霜的重量份数为10,所述的龙骨的重量份数为3,所述的牡蛎的重量份数8,所述的夏天无的重量份数为6,所述的红花的重量份数为3,所述的僵蚕的重量份数为4,所述的蛇蜕的重量份数为5,所述的山药的重量份数为8,所述的杜仲的重量份数为6,所述的牛膝的重量份数为4,所述的延胡索的重量份数为5,所述的汉桃叶的重量份数为6,所述的重金樱子的重量份数为5,所述的木瓜的重量份数为9,所述的木香的重量份数为4 ,所述的香附的重量份数为4,所述的川芎的重量份数为4,所述的垂盆草的重量份数为6,所述的伸筋草的重量份数为5,所述的防风的量份数为7。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711259353.3A CN107823383A (zh) | 2017-12-04 | 2017-12-04 | 用于治疗股骨头坏死的口服中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711259353.3A CN107823383A (zh) | 2017-12-04 | 2017-12-04 | 用于治疗股骨头坏死的口服中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107823383A true CN107823383A (zh) | 2018-03-23 |
Family
ID=61641268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711259353.3A Pending CN107823383A (zh) | 2017-12-04 | 2017-12-04 | 用于治疗股骨头坏死的口服中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107823383A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319414A (zh) * | 2001-01-19 | 2001-10-31 | 刘军 | 用于治疗股骨头坏死的药物 |
CN101347568A (zh) * | 2008-07-01 | 2009-01-21 | 王世锋 | 山药丸新制剂及质量控制方法 |
CN104000999A (zh) * | 2013-10-17 | 2014-08-27 | 胡泊 | 一种治疗股骨头缺血性坏死的中药组合物 |
CN104161917A (zh) * | 2014-08-25 | 2014-11-26 | 吕红权 | 一种治疗股骨头坏死的中药组合物 |
CN104857440A (zh) * | 2015-05-23 | 2015-08-26 | 济南邦文医药科技有限公司 | 一种治疗肾虚血瘀型中晚期股骨头坏死的中药及其制备方法 |
-
2017
- 2017-12-04 CN CN201711259353.3A patent/CN107823383A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319414A (zh) * | 2001-01-19 | 2001-10-31 | 刘军 | 用于治疗股骨头坏死的药物 |
CN101347568A (zh) * | 2008-07-01 | 2009-01-21 | 王世锋 | 山药丸新制剂及质量控制方法 |
CN104000999A (zh) * | 2013-10-17 | 2014-08-27 | 胡泊 | 一种治疗股骨头缺血性坏死的中药组合物 |
CN104161917A (zh) * | 2014-08-25 | 2014-11-26 | 吕红权 | 一种治疗股骨头坏死的中药组合物 |
CN104857440A (zh) * | 2015-05-23 | 2015-08-26 | 济南邦文医药科技有限公司 | 一种治疗肾虚血瘀型中晚期股骨头坏死的中药及其制备方法 |
Non-Patent Citations (1)
Title |
---|
李寅: "《温法纵横》", 31 January 2011, 中国中医药出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766773B (zh) | 一种治疗足跟痛病的中药 | |
CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
CN101352505B (zh) | 一种治疗跌打伤科接骨散 | |
CN104771654B (zh) | 治疗腰椎、颈椎骨质增生的中药及其制备方法 | |
CN100394955C (zh) | 一种治疗骨折、跌打损伤的中药制剂 | |
CN107095982A (zh) | 一种熥敷药剂及其制备方法 | |
CN107213347A (zh) | 一种治疗骨折的骨科接骨膏药及其制备方法 | |
CN103285203A (zh) | 用于预防和治疗骨折的中药组合物及其制备方法 | |
CN107823383A (zh) | 用于治疗股骨头坏死的口服中药 | |
CN103599321B (zh) | 一种用于治疗骨质疏松症的中药组合物 | |
CN102370834A (zh) | 接骨散 | |
CN104127620B (zh) | 一种治疗股骨头坏死的中药制剂 | |
CN103961434B (zh) | 一种骨折术后用中药组合物 | |
CN104740003A (zh) | 一种治疗腰椎间盘突出的中药 | |
CN107823604A (zh) | 一种治疗风湿骨痛的中药组合物 | |
CN102078588B (zh) | 一种治疗骨质增生的中药联合制剂及其制备方法 | |
CN106924673A (zh) | 一种治疗骨质增生的中药组合物及其药剂制备方法 | |
CN102552610A (zh) | 一种治疗骨折的中药组合物 | |
CN107308233A (zh) | 用于治疗骨关节创伤及软组织创伤的药物组合物 | |
CN101537101B (zh) | 治疗肝、四肢肌间、盆腔血管瘤及其并发症和小腿静脉曲张并溃疡出血的药物及其制造方法 | |
CN104873858A (zh) | 一种治疗功能性痛经的中药组合物 | |
CN105213865A (zh) | 一种治疗冠心病的中药组合物 | |
CN103638188A (zh) | 一种用于防治慢性骨髓炎的中药及其制备方法 | |
CN103263543B (zh) | 一种用于骨折患者术后熏蒸治疗的护理液 | |
CN114042093A (zh) | 一种用于治疗膝关节疾病的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |